We tested 24 winter boots for women from Baffin, Xero, Ugg and more, and three kept our toes toasty during the coldest months.

Every vacay outfit deserves a shoe that's cute *and* comfortable for walking around all day and night. View Entire Post › ...

Solo travel is an enriching experience. It doesn’t just allow you to see the world, experience new things and awaken the open ...

We’ve gathered the best travel gear and accessories still on sale at Amazon. With prices starting at just $5, stock up now on ...

From sandals to sneakers, these will let you enjoy a full day of sightseeing without having to find somewhere to sit every ten minutes. Imagine that. View Entire Post › ...

As the most discerning, up-to-the-minute voice in all things travel, Condé Nast Traveler is the global citizen’s bible and muse, offering both inspiration and vital intel. We understand that ...

The anti-TL1A antibody allowed significantly more inflammatory bowel disease (IBD) patients to go into remission than those taking placebo treatment. Teva announced it was partnering with Sanofi to ...

On Tuesday, Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Sanofi SA’s (NASDAQ:SNY) Phase 2b RELIEVE UCCD study met its primary endpoints in patients with ulcerative colitis (UC ...

Teva Pharmaceuticals' shares soared and Sanofi's stock moved higher following positive results from the latest trial of their jointly developed treatment for inflammatory bowel disease. The ...

17 story has been corrected to say the results were for ulcerative colitis, not for both the diseases, in paragraph 5) Teva and Sanofi said last year they would collaborate on developing a ...

Duvakitug isn't just another drug in Teva's pipelineit's the drug. With consistent efficacy across patient groups and no major safety hiccups, this TL1A antibody therapy is now a frontrunner in ...